Fitness effects of blaCTX-M-15-harbouring F2:A1:B- plasmids on their native Escherichia coli ST131 H30Rx hosts
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
18-23532S
Czech Science Foundation
NU20J-05-00033
Ministry of Health of the Czech Republic
LQ1601
Central European Institute of Technology
209/2021/FVHE
Internal Grant Agency of University of Veterinary Sciences Brno
PubMed
35880751
DOI
10.1093/jac/dkac250
PII: 6650071
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- beta-laktamasy genetika farmakologie MeSH
- Escherichia coli * genetika MeSH
- infekce vyvolané Escherichia coli * MeSH
- lidé MeSH
- plazmidy genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
- beta-laktamasy MeSH
OBJECTIVES: To investigate the fitness effects of large blaCTX-M-15-harbouring F2:A1:B- plasmids on their native Escherichia coli ST131 H30Rx hosts. METHODS: We selected five E. coli ST131 H30Rx isolates of diverse origin, each carrying an F2:A1:B- plasmid with the blaCTX-M-15 gene. The plasmid was eliminated from each isolate by displacement using an incompatible curing plasmid, pMDP5_cureEC958. WGS was performed to obtain complete chromosome and plasmid sequences of original isolates and to detect chromosomal mutations in 'cured' clones. High-throughput competition assays were conducted to determine the relative fitness of cured clones compared with the corresponding original isolates. RESULTS: We were able to successfully eliminate the F2:A1:B- plasmids from all five original isolates using pMDP5_cureEC958. The F2:A1:B- plasmids produced non-significant fitness effects in three isolates and moderate reductions in relative fitness (3%-4%) in the two remaining isolates. CONCLUSIONS: We conclude that F2:A1:B- plasmids pose low fitness costs in their E. coli ST131 H30Rx hosts. This plasmid-host fitness compatibility is likely to promote the maintenance of antibiotic resistance in this clinically important E. coli lineage.
Biomedical Centre Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Central European Institute of Technology University of Veterinary Sciences Brno Brno Czech Republic
Centro Nacional de Biotecnologia CSIC Madrid Spain
Department of Microbiology Hospital Universitario Ramon y Cajal Madrid Spain
Institute of Biodiversity Animal Health and Comparative Medicine University of Glasgow Glasgow UK
Structural Biology Brussels Vrije Universiteit Brussel Brussels Belgium
Citace poskytuje Crossref.org